Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
American Society of Clinical Oncology confers highest honor upon Prof Hagop Kantarjian
2023-06-05 12:30
Live from ASCO 2023 | Updated Data of Olverembatinib in SDH-Deficient GIST including a CBR of 93.8% Signals a Potential Clinical Breakthrough
2023-06-05 11:51
Harbour BioMed Announces First Patient Dosed in Phase I Study of First-in-Class Anti-B7H7 (HHLA2) Antibody HBM1020
2023-06-05 09:01
LOTTE BIOLOGICS to Kick off their CDMO Business Campaign at 'BIO International Convention 2023'
2023-06-05 08:27
VVN539 met primary study endpoints in US phase IIa clinical study for the treatment of glaucoma
2023-06-05 08:00
Gracell Biotechnologies Presents Updated Data of Deep and Durable Responses for FasTCAR-T GC012F in Relapsed/Refractory Multiple Myeloma at 2023 ASCO Annual Meeting
2023-06-04 02:15
Sanyou launches new European offices and continues to promote global business landscape
2023-06-03 20:05
United Imaging to Unveil Ultra-Modern MRI Technology Platform at ISMRM in Toronto
2023-06-02 22:00
Trajan's Microsampling Devices Meet IVDR Compliance in Europe, UK
2023-06-02 20:00
Waterdrop Inc. Announces First Quarter 2023 Unaudited Financial Results
2023-06-02 18:16
TWi Biotechnology Exploring Promising Treatment for Granuloma Annulare (GA)
2023-06-02 15:51
NMPA accepted Akeso's ebronucimab (PCSK9) marketing application in two cardiovascular indications
2023-06-02 11:43
GC Biopharma receives a business license for the construction of a plasma fractionation plant and technology transfer in Indonesia
2023-06-02 08:35
GenEros to Present Promising Results of GEC255 Phase I Clinical Trial for Advanced NSCLC Patients with KRAS G12C Mutation
2023-06-01 22:15
Impact Therapeutics Entered into Global Partnership with Eikon Therapeutics to Develop and Commercialize PARP1 Selective Inhibitors
2023-06-01 20:30
Aravax doses first patient in Phase 2 peanut allergy clinical trials
2023-06-01 20:00
BIORCHESTRA Invited to Present Update on Central Nervous System Lead Program (BMD-001) and IV-Formulated siRNA Data at BIO2023 International Conference
2023-06-01 20:00
Seegene Obtains IVDR Certification for 30 Diagnostic Assays
2023-06-01 19:00
Kombucha Continues to Trend! TCI Received the Golden Award at the Geneva International Exhibition of Inventions
2023-06-01 18:06
Xinhua Silk Road: Activity to promote TCM cultural exchanges and cooperation between China and Luxembourg completes success
2023-06-01 17:37
1
93
94
95
96
97
812